Opioid rotation for toxicity reduction in terminal cancer patients.
about
Opioid switching to improve pain relief and drug tolerabilityFentanyl for chronic painFentanyl for chronic painOpioid switching to improve pain relief and drug tolerabilityMorphine and alternative opioids in cancer pain: the EAPC recommendationsStrong opioids for cancer painAlternative opioids to morphine in palliative care: a review of current practice and evidenceRetrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine.A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.Morphine to methadone conversion: an interpretation of published data.The role of morphine glucuronides in cancer pain.Opioid rotation for cancer pain: rationale and clinical aspects.Recent developments: management of pain.Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development.Palliative care--new approaches to the problem of suffering.Efficacy of opioid rotation to continuous parenteral hydromorphone in advanced cancer patients failing on other opioids.Opioid rotation in clinical practice.Toward a systematic approach to opioid rotation.Recent advances in the use of opioids for cancer painThe opioid rotation ratio of hydrocodone to strong opioids in cancer patientsIntravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal.Pharmacotherapy of cancer-related episodic pain.Anticipating and treating opioid-associated adverse effects.Analgesia for patients with advanced disease: IIntrathecal hydromorphone for chronic nonmalignant pain: a retrospective study.Pharmacological management of metastatic boney pain.Emerging analgesics in cancer pain management.Equianalgesic doses of opioids - their use in clinical practice.A period of immobility after remifentanil administration protects from nausea: an experimental randomized cross-over study.Opioid switch in palliative care, opioid choice by clinical need and opioid availability.Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trialFrequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids.Management strategies for pain in breast carcinoma patients: current opinions and future perspectives.Opioid rotation in patients initiated on oxycodone or morphine: a register study.Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.Opioids switching with transdermal systems in chronic cancer pain.Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19Morphine-induced hallucinations - resolution with switching to oxycodone: a case report and review of the literature.
P2860
Q24197642-1015E1A1-6496-403E-87DC-27D2033DCE7DQ24203830-143E8B09-7DB3-4810-A6CA-0B76282DC2A3Q24242219-9E44EC3E-4B7C-4876-AE78-AA0172354771Q24246707-3125A59D-1B67-4BE9-96E2-49D9BA63D6DCQ24648711-8BD79207-F7A0-4142-8EA7-862FB8A05513Q28353103-EB84C0F8-A996-4E3A-B08A-EF5229BB29DBQ28365903-C67F9B56-9E3C-400A-92EB-30E075706DCCQ32047672-33E2D928-108D-4EF1-9F60-647E818088A5Q33183931-2A75B512-3E94-4BEB-92E5-7E5D34BDE0A7Q33606762-AEFB1FA0-5C01-47EC-BBF8-14983F59ABE6Q33727191-807140DA-77C6-43FF-8BBB-1555C978B31BQ33765787-D9C77677-EDAE-4186-8513-53A514E5475FQ33814370-AED700FC-6F60-4268-8C6C-47CAEF1EBC8CQ33844380-2F8AED72-3726-4C53-84F2-89600E031741Q33983652-CF4656E7-7F3E-402D-9CA6-63D9947B6032Q34000978-BCE98B23-BBDA-41AC-A677-C7FA114860C1Q34305249-3E9E0ED1-67B3-4464-A754-64F75F4A03DCQ34394425-2CF027DE-D9B2-4E2D-B6DE-71D394E334C6Q34418203-6A583A3F-DA85-4480-9B7D-2A926F90AFE8Q34458000-07F9338D-0182-42FE-A9D0-A42463AA8715Q34519887-DBD0BF5E-16F3-4B93-B9D8-4CEF39F25590Q34552445-601F49CF-5D62-493C-98C7-BD187568D6DBQ34580479-61ACBFC0-F8FD-49C3-8EFB-B56D7CF88E45Q35095194-94B23A9A-7B55-4A9C-A4B7-EF965EB2EFEFQ35194392-A146E45D-8951-45B9-B152-0CC73F5106FDQ35518956-C5AAE018-34EE-47DE-8D0A-C153605719E3Q35752995-F7F19A41-016B-4C53-BC16-8702EF22808BQ35814415-C05EFD79-AEE7-46F7-8D3D-73904E0E18A2Q36066043-E2AE2A0F-B37C-4021-AC04-A0FCA28E20D8Q36110411-B732D0B8-1BD6-4980-9AF0-777B14CD612CQ36159660-43D05A55-D433-4970-8C1E-E720F01959ADQ36247567-97FB6CA9-896C-47DA-A7AB-39A3102703A6Q36490039-5695E41C-A03E-4711-8B85-1B1DFBCC9905Q36630474-C3FBA058-1E28-4A80-95DE-AEFD52B58B0FQ36845203-9E13D3DB-2020-492E-9B26-A8DF4E08C8E2Q36870860-5D87CCDE-1935-48D2-9EEA-4A2BD8A73B47Q37065797-AF6BD744-AB00-432D-812E-05A4ADCE1028Q37198162-061703C0-DD97-4BFE-86E7-47CE73E91D1BQ37667893-5DC87A55-9D3C-4274-8D1C-19A4FE1EAAA7Q37671628-130CA255-C088-48D3-8DAD-68E6D5C74EE2
P2860
Opioid rotation for toxicity reduction in terminal cancer patients.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Opioid rotation for toxicity reduction in terminal cancer patients.
@ast
Opioid rotation for toxicity reduction in terminal cancer patients.
@en
Opioid rotation for toxicity reduction in terminal cancer patients.
@nl
type
label
Opioid rotation for toxicity reduction in terminal cancer patients.
@ast
Opioid rotation for toxicity reduction in terminal cancer patients.
@en
Opioid rotation for toxicity reduction in terminal cancer patients.
@nl
prefLabel
Opioid rotation for toxicity reduction in terminal cancer patients.
@ast
Opioid rotation for toxicity reduction in terminal cancer patients.
@en
Opioid rotation for toxicity reduction in terminal cancer patients.
@nl
P2093
P1476
Opioid rotation for toxicity reduction in terminal cancer patients.
@en
P2093
Suarez-Almazor M
de Stoutz ND
P304
P356
10.1016/0885-3924(95)90924-C
P577
1995-07-01T00:00:00Z